These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2371300)

  • 1. Current status of the Gene-Tox Program.
    Auletta AE; Kier LD; Mitchell AD
    Prog Clin Biol Res; 1990; 340D():273-81. PubMed ID: 2371300
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on the US EPA recommendation for genotoxicity guidelines on chemicals.
    Ishidate M
    Mutat Res; 1992 Aug; 272(1):79-80. PubMed ID: 1380121
    [No Abstract]   [Full Text] [Related]  

  • 3. Epidemiology of occupational carcinogens and mutagens.
    Ruder AM
    Occup Med; 1996; 11(3):487-512. PubMed ID: 8887381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term tests for defining mutagenic carcinogens.
    Waters MD; Stack HF; Jackson MA
    IARC Sci Publ; 1999; (146):499-536. PubMed ID: 10353401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Selection and application of mutagenicity tests in identification of carcinogens and mutagens. (II)].
    Wang JN
    Zhonghua Yu Fang Yi Xue Za Zhi; 1983 Sep; 17(5):313-5. PubMed ID: 6689553
    [No Abstract]   [Full Text] [Related]  

  • 6. Development and impact of the Gene-Tox-Program, genetic activity profiles, and their computerized data bases.
    Waters MD
    Environ Mol Mutagen; 1994; 23 Suppl 24():67-72. PubMed ID: 8162911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are evaluations of carcinogenicity by various committees worth comparing?
    Boffetta P; Saracci R; Vainio H; Wilbourn J; Tomatis L
    Med Lav; 1993; 84(4):332-3. PubMed ID: 8255265
    [No Abstract]   [Full Text] [Related]  

  • 8. An approach to identifying specialized batteries of bioassays for specific classes of chemicals: class analysis using mutagenicity and carcinogenicity relationships and phylogenetic concordance and discordance patterns. 1. Composition and analysis of the overall data base. A report of phase II of the U.S. Environmental Protection Agency Gene-Tox Program.
    Ray VA; Kier LD; Kannan KL; Haas RT; Auletta AE; Wassom JS; Nesnow S; Waters MD
    Mutat Res; 1987 May; 185(3):197-241. PubMed ID: 3574331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies and testing methods for identifying mutagenic risks.
    MacGregor JT; Casciano D; Müller L
    Mutat Res; 2000 Nov; 455(1-2):3-20. PubMed ID: 11113464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Researchers exploring faster alternatives to 2-year test for carcinogenicity.
    Schmidt C
    J Natl Cancer Inst; 2006 Feb; 98(4):228-30. PubMed ID: 16478737
    [No Abstract]   [Full Text] [Related]  

  • 11. Mutagen assay with Arabidopsis. A report of the U.S. Environmental Protection Agency Gene-Tox Program.
    Rédei GP
    Mutat Res; 1982 Sep; 99(2):243-55. PubMed ID: 7121505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The induction of micronuclei as a measure of genotoxicity. A report of the U.S. Environmental Protection Agency Gene-Tox Program.
    Heddle JA; Hite M; Kirkhart B; Mavournin K; MacGregor JT; Newell GW; Salamone MF
    Mutat Res; 1983 Sep; 123(1):61-118. PubMed ID: 6888413
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of reduced protocols for carcinogenicity testing of chemicals: report of a joint EPA/NIEHS workshop.
    Lai DY; Baetcke KP; Vu VT; Cotruvo JA; Eustis SL
    Regul Toxicol Pharmacol; 1994 Apr; 19(2):183-201. PubMed ID: 8041916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
    Kirkland D; Aardema M; Müller L; Makoto H
    Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspects of database construction and interrogation of relevance to the accurate prediction of rodent carcinogenicity and mutagenicity.
    Ashby J
    Environ Health Perspect; 1991 Dec; 96():97-100. PubMed ID: 1820286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A classification framework and practical guidance for establishing a mode of action for chemical carcinogens.
    Butterworth BE
    Regul Toxicol Pharmacol; 2006 Jun; 45(1):9-23. PubMed ID: 16530901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personal comments on 'Environmental Protection Agency' proposed guidelines for mutagenicity risk assessment.
    Sobels FH
    Mutat Res; 1985 Aug; 147(4):211-6. PubMed ID: 4022034
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies in comparative chemical mutagenesis.
    Sobels FH
    Environ Mutagen; 1985; 7(5):759-73. PubMed ID: 3930240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comments and perspective on the EPA workshop on "The relationship between short-term test information and carcinogenicity".
    Kier LD
    Environ Mol Mutagen; 1988; 11(1):147-57. PubMed ID: 2892675
    [No Abstract]   [Full Text] [Related]  

  • 20. Dichlorvos: a regulatory conundrum.
    Mennear JH
    Regul Toxicol Pharmacol; 1998 Jun; 27(3):265-72. PubMed ID: 9693077
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.